Míriam Molina‐Arcas

Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA

Matthew A. Coelho, Sophie de Carné Trécesson, Sareena Rana et al. · Immunity · 2017 · 665 citations · Full text

Medicine, Cancer Biology, Oncology +17

The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer

Madhu Kumar, David C. Hancock, Míriam Molina‐Arcas et al. · Cell · 2012 · 267 citations · Full text

Medicine, Genetics, Oncology +12

RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

Kevin W. Ng, Jesse Boumelha, Katey S.S. Enfield et al. · Nature · 2023 · 249 citations · Full text

Life Sciences, Immunology, Oncology +17

Development of combination therapies to maximize the impact of KRAS-G12C inhibitors in lung cancer

Míriam Molina‐Arcas, Christopher Moore, Sareena Rana et al. · Science Translational Medicine · 2019 · 220 citations

Medicine, Oncology, Pharmacology +16

Nucleoside transporter profiles in human pancreatic cancer cells: role of hCNT1 in 2',2'-difluorodeoxycytidine- induced cytotoxicity.

José Manuel García-Manteiga, Míriam Molina‐Arcas, F. Javier Casado et al. · PubMed · 2003 · 213 citations

Medicine, Oncology, Pharmacology +11